{"disease":{"id":"dry-eye","name":"dry eye"},"drugs":{"marketed":[{"drug_id":"perfluorohexyloctane","indication_name":"Dry Eye Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Miebo","generic_name":"PERFLUOROHEXYLOCTANE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"","drug_class":"Semifluorinated Alkane [EPC]","quality_score":44,"revenue":null,"mechanism":"Miebo works by mimicking the natural oils in the eyes to help maintain moisture."},{"drug_id":"chembl-chembl160","indication_name":"Dry Eye Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CYCLOSPORINE","company_name":"","drug_phase":"marketed","molecular_target":"calcineurin","drug_class":"Calcineurin Inhibitor Immunosuppressant [EPC]","quality_score":35,"revenue":null,"mechanism":"Cyclosporine, a calcineurin inhibitor, selectively modulates the immune system."},{"drug_id":"perfluorohexyloctane","indication_name":"Dry eye disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Miebo","generic_name":"PERFLUOROHEXYLOCTANE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"","drug_class":"Semifluorinated Alkane [EPC]","quality_score":44,"revenue":null,"mechanism":"Miebo works by mimicking the natural oils in the eyes to help maintain moisture."},{"drug_id":"hypromellose","indication_name":"dryness of the eye","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vista Gonio Eye Lubricant","generic_name":"HYPROMELLOSE","company_name":"Red Wedding LLC","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":13,"revenue":null,"mechanism":""},{"drug_id":"dextran","indication_name":"dryness of the eye","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"GoodSense Eye Drops Advanced Relief Moisturizer","generic_name":"DEXTRAN","company_name":"Allergan","drug_phase":"marketed","molecular_target":"","drug_class":"Plasma Volume Expander [EPC]","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"acoltremon","indication_name":"dry eye disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tryptyr","generic_name":"ACOLTREMON","company_name":"Alcon Labs Inc","drug_phase":"marketed","molecular_target":"","drug_class":"TRPM8 Thermoreceptor Agonist [EPC]","quality_score":41,"revenue":null,"mechanism":"Tryptyr works by modulating the function of the lacrimal gland to increase tear production."},{"drug_id":"acoltremon","indication_name":"dry eye disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tryptyr","generic_name":"ACOLTREMON","company_name":"Alcon Labs Inc","drug_phase":"marketed","molecular_target":"","drug_class":"TRPM8 Thermoreceptor Agonist [EPC]","quality_score":41,"revenue":null,"mechanism":"Tryptyr works by modulating the function of the lacrimal gland to increase tear production."},{"drug_id":"miebo","indication_name":"Dry eye disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Miebo","company_name":"Bausch & Lomb Incorporated","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":8,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03938207","title":"Dry Eye Syndrome, Healthy Control, Sjögren's Syndrome and Other Inflammation Disease in Taiwan Biobank","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Taipei Veterans General Hospital, Taiwan","has_results":false},{"nct_id":"NCT05247333","title":"Implementation of a Minor Ailment Service in Community Pharmacy Practice","phase":"NA","overall_status":"COMPLETED","enrollment_count":20987,"lead_sponsor_name":"Universidad de Granada","has_results":false},{"nct_id":"NCT04744805","title":"Mask-associated Dry Eye Symptoms in China","phase":"","overall_status":"UNKNOWN","enrollment_count":6262,"lead_sponsor_name":"Tianjin Eye Hospital","has_results":false},{"nct_id":"NCT03135327","title":"Clinical Applications of Advanced Ophthalmic Imaging","phase":"NA","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"University of Miami","has_results":false},{"nct_id":"NCT06605495","title":"Using Dry Eye As a Disease Model, Investigators Demonstrated the Optimal Selection of Individualized Clinical Interventions and the Superiority of Dynamic Treatment Discrimination in Chinese Medicine.","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":4000,"lead_sponsor_name":"Xuejing Lu","has_results":false},{"nct_id":"NCT07457021","title":"A Study to Evaluate the Safety and Effectiveness of Perfluorohexyloctane Eye Drops on Treatment of Dry Eye Disease (DED) Related to Meibomian Gland Dysfunction (MGD)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Xiamen Ophthalmology Center Affiliated to Xiamen University","has_results":false},{"nct_id":"NCT05476068","title":"Dry Eye Under China's Dynamic COVID-zero Strategy","phase":"","overall_status":"COMPLETED","enrollment_count":1807,"lead_sponsor_name":"Yifeng Yu","has_results":false},{"nct_id":"NCT04747288","title":"Objective Measurement With TCM Pattern for AIDDES","phase":"","overall_status":"UNKNOWN","enrollment_count":1800,"lead_sponsor_name":"Taipei Veterans General Hospital, Taiwan","has_results":false},{"nct_id":"NCT06621446","title":"The Beijing Adult Dry Eye Cohort Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Beijing Tongren Hospital","has_results":false},{"nct_id":"NCT06499753","title":"Differences in Dry Eye Symptoms Related to Geographic Location in Spain and Impact of Artificial Tears Use","phase":"","overall_status":"COMPLETED","enrollment_count":1033,"lead_sponsor_name":"University of Valladolid","has_results":false},{"nct_id":"NCT06018571","title":"Burden of Illness and Treatment Assessment of Patients With Dry Eye Disease: A Cross-Sectional Survey of Real-World Patients With Dry Eye Disease in the US","phase":"","overall_status":"COMPLETED","enrollment_count":946,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT04899518","title":"ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":922,"lead_sponsor_name":"Allysta Pharmaceutical","has_results":false},{"nct_id":"NCT04523129","title":"ESSENCE 2: CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":834,"lead_sponsor_name":"Novaliq GmbH","has_results":true},{"nct_id":"NCT06879782","title":"Phase III Clinical Study of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":820,"lead_sponsor_name":"Lunan Better Pharmaceutical Co., LTD.","has_results":false},{"nct_id":"NCT04036292","title":"Evaluation of the Efficacy and Safety of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":758,"lead_sponsor_name":"Oyster Point Pharma, Inc.","has_results":true},{"nct_id":"NCT04735393","title":"A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":757,"lead_sponsor_name":"Aldeyra Therapeutics, Inc.","has_results":true},{"nct_id":"NCT05695781","title":"Assessment of the Safety and Efficacy of BRM421 Ophthalmic Solutions in Dry Eye Subjects.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":740,"lead_sponsor_name":"BRIM Biotechnology Inc.","has_results":false},{"nct_id":"NCT01743729","title":"A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":720,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT04391894","title":"A Study to Assess the Safety and Efficacy of ECF843 vs Vehicle in Subjects With Dry Eye Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":718,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT02284516","title":"A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":711,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT03937882","title":"Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":700,"lead_sponsor_name":"ReGenTree, LLC","has_results":false},{"nct_id":"NCT06360133","title":"Study of 5% VVN001 Ophthalmic Solution in Dry Eye Disease","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"VivaVision Biotech, Inc","has_results":false},{"nct_id":"NCT04633213","title":"A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":674,"lead_sponsor_name":"Harbour BioMed (Guangzhou) Co. Ltd.","has_results":false},{"nct_id":"NCT05403827","title":"A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":644,"lead_sponsor_name":"Kowa Research Institute, Inc.","has_results":true},{"nct_id":"NCT04541888","title":"Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":644,"lead_sponsor_name":"Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.","has_results":false},{"nct_id":"NCT05848128","title":"Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":642,"lead_sponsor_name":"Mimetogen Pharmaceuticals USA, Inc.","has_results":false},{"nct_id":"NCT03846453","title":"A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":637,"lead_sponsor_name":"HanAll BioPharma Co., Ltd.","has_results":true},{"nct_id":"NCT03652415","title":"DRy Eye Outcome and Prescription Study","phase":"","overall_status":"UNKNOWN","enrollment_count":635,"lead_sponsor_name":"Guy's and St Thomas' NHS Foundation Trust","has_results":false},{"nct_id":"NCT03925727","title":"Tavilermide Ophthalmic Solution for the Treatment of Dry Eye","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":623,"lead_sponsor_name":"Mimetogen Pharmaceuticals USA, Inc.","has_results":true},{"nct_id":"NCT04567329","title":"Effect of NOV03 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Mojave Study)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":620,"lead_sponsor_name":"Bausch & Lomb Incorporated","has_results":true},{"nct_id":"NCT04206020","title":"Vehicle-Controlled Study of SkQ1 as Treatment for Dry-eye Syndrome","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":610,"lead_sponsor_name":"Mitotech, SA","has_results":true},{"nct_id":"NCT04658238","title":"Ocular Microbiome and Immune System in Dry Eyes","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT04139798","title":"Perfluorohexylcotane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Gobi Study)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":599,"lead_sponsor_name":"Bausch & Lomb Incorporated","has_results":true},{"nct_id":"NCT01421498","title":"Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":588,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT05201170","title":"A Phase 3, Multi-Center Study Evaluating PL9643 in Patients with Dry Eye","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":575,"lead_sponsor_name":"Palatin Technologies, Inc","has_results":false},{"nct_id":"NCT05096546","title":"The Proportion of Patients Diagnosed With Dry Eye by the Asia Dry Eye Society (ADES) Criteria in Taiwan (DECS-TW)","phase":"","overall_status":"UNKNOWN","enrollment_count":540,"lead_sponsor_name":"Far Eastern Memorial Hospital","has_results":false},{"nct_id":"NCT07524725","title":"Effect of Behavioral Intervention (Baduanjin Alone or Laughter Exercise Plus Artificial Tears) Versus Artificial Tear on Dry Eye Disease: a Randomised Controlled Trial","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":540,"lead_sponsor_name":"Zhongshan Ophthalmic Center, Sun Yat-sen University","has_results":false},{"nct_id":"NCT04413370","title":"Dry Eye Screening and Referral System","phase":"","overall_status":"UNKNOWN","enrollment_count":518,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT02365519","title":"LME636 in the Relief of Persistent Ocular Discomfort in Subjects With Severe Dry Eye Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":514,"lead_sponsor_name":"Alcon, a Novartis Company","has_results":true},{"nct_id":"NCT04147650","title":"Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye Syndrome","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":508,"lead_sponsor_name":"Aurinia Pharmaceuticals Inc.","has_results":true},{"nct_id":"NCT04109170","title":"Dry Eye Evaluation System Based on Bioinformatics","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Huaxia Eye Hospital Group","has_results":false},{"nct_id":"NCT05605314","title":"Clinical Cohort Study in Patients With Different Subtypes of Primary Sjogren Syndrome Related Dry Eye","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT05360966","title":"Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":467,"lead_sponsor_name":"Aerie Pharmaceuticals","has_results":true},{"nct_id":"NCT05285644","title":"Study Evaluating the Safety and Efficacy of AR-15512","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":465,"lead_sponsor_name":"Aerie Pharmaceuticals","has_results":true},{"nct_id":"NCT07020871","title":"Correlation of Dry Eye Disease, Problematic Smartphone Use and Sleep Quality in Adolescents and Young Adults","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":453,"lead_sponsor_name":"Wei XIA, PhD","has_results":false},{"nct_id":"NCT03764735","title":"Study of SkQ1 as Treatment for Dry-eye Syndrome","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":452,"lead_sponsor_name":"Mitotech, SA","has_results":true},{"nct_id":"NCT05653921","title":"Prospective Study to Validate the Imaging Biomarker for NCP (R33)","phase":"","overall_status":"SUSPENDED","enrollment_count":438,"lead_sponsor_name":"Tufts Medical Center","has_results":false},{"nct_id":"NCT04127851","title":"Evaluating HA 0.15% Compared With Cyclosporine 0.05%, and Efficacy of Combination Therapy in Dry Eye Disease Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":438,"lead_sponsor_name":"Taejoon Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06717152","title":"Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":427,"lead_sponsor_name":"Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd.","has_results":false},{"nct_id":"NCT03879863","title":"The RENEW Trial: A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Adaptive Phase 3 Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":422,"lead_sponsor_name":"Aldeyra Therapeutics, Inc.","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}